Simcere Pharmaceutical Group Limited - Net Worth and Insider Trading

Simcere Pharmaceutical Group Limited Net Worth

The estimated net worth of Simcere Pharmaceutical Group Limited is at least $48 Million dollars as of 2024-11-07. Simcere Pharmaceutical Group Limited is the 2101 Beneficial owner of 3D Medicines Inc and owns about 23,047,468 shares of 3D Medicines Inc (HKSE:01244) stock worth over $48 Million. Details can be seen in Simcere Pharmaceutical Group Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Simcere Pharmaceutical Group Limited has not made any transactions after 2023-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Simcere Pharmaceutical Group Limited owns 1 companies in total, including 3D Medicines Inc (HKSE:01244) .

Click here to see the complete history of Simcere Pharmaceutical Group Limited’s form 4 insider trades.

Insider Ownership Summary of Simcere Pharmaceutical Group Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01244	3D Medicines Inc	2023-07-21	2101 Beneficial owner

Simcere Pharmaceutical Group Limited Latest Holdings Summary

Simcere Pharmaceutical Group Limited currently owns a total of 1 stock. Simcere Pharmaceutical Group Limited owns 23,047,468 shares of 3D Medicines Inc (HKSE:01244) as of July 21, 2023, with a value of $48 Million.

Latest Holdings of Simcere Pharmaceutical Group Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01244	3D Medicines Inc	2023-07-21	23,047,468	2.09	48,169,208

Holding Weightings of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Simcere Pharmaceutical Group Limited has made a total of 3 transactions in 3D Medicines Inc (HKSE:01244) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in 3D Medicines Inc is the sale of 0 shares on July 21, 2023, which brought Simcere Pharmaceutical Group Limited around $0.

Insider Trading History of Simcere Pharmaceutical Group Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Simcere Pharmaceutical Group Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Simcere Pharmaceutical Group Limited Ownership Network

Ownership Network List of Simcere Pharmaceutical Group Limited

No Data

Ownership Network Relation of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited Owned Company Details

What does 3D Medicines Inc do?

Who are the key executives at 3D Medicines Inc?

Simcere Pharmaceutical Group Limited is the 2101 Beneficial owner of 3D Medicines Inc. Other key executives at 3D Medicines Inc include 2101 Beneficial owner Gong Zhaolong , 2101 Beneficial owner Zhu Pai , and 2101 Beneficial owner Dragon Prosper Holdings Limited .

3D Medicines Inc (HKSE:01244) Insider Trades Summary

Over the past 18 months, Simcere Pharmaceutical Group Limited made 1 insider transaction in 3D Medicines Inc (HKSE:01244) with a net sale of 0. Other recent insider transactions involving 3D Medicines Inc (HKSE:01244) include a net sale of 97,000 shares made by Zhu Pai , a net sale of 0 shares made by Gong Zhaolong , and a net sale of 0 shares made by Dragon Prosper Holdings Limited .

In summary, during the past 3 months, insiders sold 0 shares of 3D Medicines Inc (HKSE:01244) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 100,000 shares of 3D Medicines Inc (HKSE:01244) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 97,000 shares.

3D Medicines Inc (HKSE:01244)'s detailed insider trading history can be found in Insider Trading Tracker table.

3D Medicines Inc Insider Transactions

No Available Data

Simcere Pharmaceutical Group Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Simcere Pharmaceutical Group Limited. Currently GuruFocus does not have mailing address information for Simcere Pharmaceutical Group Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.